BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27345657)

  • 1. Classification of TP53 mutations and HPV predict survival in advanced larynx cancer.
    Scheel A; Bellile E; McHugh JB; Walline HM; Prince ME; Urba S; Wolf GT; Eisbruch A; Worden F; Carey TE; Bradford C
    Laryngoscope; 2016 Sep; 126(9):E292-9. PubMed ID: 27345657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer.
    Kumar B; Cordell KG; D'Silva N; Prince ME; Adams ME; Fisher SG; Wolf GT; Carey TE; Bradford CR
    Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):363-9. PubMed ID: 18427001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in advanced larynx cancer.
    Bradford CR; Kumar B; Bellile E; Lee J; Taylor J; D'Silva N; Cordell K; Kleer C; Kupfer R; Kumar P; Urba S; Worden F; Eisbruch A; Wolf GT; Teknos TN; Prince ME; Chepeha DB; Hogikyan ND; Moyer JS; Carey TE
    Laryngoscope; 2014 Jan; 124(1):179-87. PubMed ID: 23775802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.
    Kumar B; Cordell KG; Lee JS; Worden FP; Prince ME; Tran HH; Wolf GT; Urba SG; Chepeha DB; Teknos TN; Eisbruch A; Tsien CI; Taylor JM; D'Silva NJ; Yang K; Kurnit DM; Bauer JA; Bradford CR; Carey TE
    J Clin Oncol; 2008 Jul; 26(19):3128-37. PubMed ID: 18474878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
    Geisler S; Lønning PE; Aas T; Johnsen H; Fluge O; Haugen DF; Lillehaug JR; Akslen LA; Børresen-Dale AL
    Cancer Res; 2001 Mar; 61(6):2505-12. PubMed ID: 11289122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
    Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
    J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common.
    Kashofer K; Winter E; Halbwedl I; Thueringer A; Kreiner M; Sauer S; Regauer S
    Mod Pathol; 2017 Jul; 30(7):1013-1020. PubMed ID: 28387325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non-small cell lung cancer.
    Jiang W; Cheng H; Yu L; Zhang J; Wang Y; Liang Y; Lou F; Wang H; Cao S
    Cancer Med; 2023 Mar; 12(6):6649-6658. PubMed ID: 36440695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
    Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors.
    Manjarrez ME; Ocadiz R; Valle L; Pacheco C; Marroquin A; De la Torre C; Selman M; Gariglio P
    Clin Cancer Res; 2006 Dec; 12(23):6946-51. PubMed ID: 17145812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of HPV 16, HPV 18, p16 expression in advanced stage laryngeal cancer patients and prognostic significance.
    Dogantemur S; Ozdemir S; Uguz A; Surmelioglu O; Dagkiran M; Tarkan O; Tuncer U
    Braz J Otorhinolaryngol; 2020; 86(3):351-357. PubMed ID: 31899126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
    Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
    J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.
    Malisic E; Jankovic R; Jakovljevic K; Radulovic S
    J BUON; 2011; 16(4):701-7. PubMed ID: 22331725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.
    Wang Z; Xia RH; Ye DX; Li J
    PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential clinical implications of HPV status and expressions of p53 and cyclin D1 among oropharyngeal cancer patients.
    Lu XJD; Liu KYP; Soares RC; Thomson T; Prisman E; Wu J; Poh CF
    J Oral Pathol Med; 2018 Nov; 47(10):945-953. PubMed ID: 30191616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Prognostic Value of HPV among Tunisian Patients with Laryngeal Cancer and Relationship between DNA HPV and p16, IGF-1R, Survivin, p53 Expressions.
    Ben Elhadj M; Fourati A; El Amine O; Goucha A; El May A; El May MV; Mokni Baizig N
    Ann Otol Rhinol Laryngol; 2020 Sep; 129(9):863-871. PubMed ID: 32364419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human papillomavirus on cell cycle-related proteins p16INK4A, p21waf1/cip1, p53 and cyclin D1 in sinonasal inverted papilloma and laryngeal carcinoma. An in situ hybridization study.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    Folia Histochem Cytobiol; 2011; 49(1):34-40. PubMed ID: 21526487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study.
    Huang Q; Li F; Ji M; Lin L; Hu C
    BMC Cancer; 2023 Apr; 23(1):324. PubMed ID: 37024846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.